NANNUCCI, SERENA
 Distribuzione geografica
Continente #
NA - Nord America 1.209
EU - Europa 821
AS - Asia 223
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.256
Nazione #
US - Stati Uniti d'America 1.209
RU - Federazione Russa 332
IT - Italia 168
SE - Svezia 102
IE - Irlanda 99
CN - Cina 62
HK - Hong Kong 59
PL - Polonia 58
SG - Singapore 57
FI - Finlandia 23
IN - India 19
DE - Germania 11
GB - Regno Unito 11
TR - Turchia 11
JO - Giordania 10
UA - Ucraina 5
KR - Corea 4
BE - Belgio 3
FR - Francia 3
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ES - Italia 2
NL - Olanda 2
EU - Europa 1
TW - Taiwan 1
Totale 2.256
Città #
Fairfield 185
Chandler 125
Woodbridge 110
Ashburn 102
Dublin 99
Seattle 94
Houston 91
Cambridge 77
Wilmington 76
Warsaw 58
Hong Kong 40
Singapore 40
Florence 39
Lawrence 35
Altamura 34
Beijing 32
Ann Arbor 31
Princeton 30
Mumbai 17
Boston 15
Shanghai 11
Izmir 10
Medford 10
New York 10
Boardman 9
Falls Church 9
Kent 8
Dearborn 7
Jacksonville 7
Santa Clara 6
Buffalo 5
Cantù 5
Los Angeles 5
San Diego 4
Detroit 3
Gallarate 3
Ghent 3
Ponte Buggianese 3
Salerno 3
Seoul 3
Treviso 3
West Jordan 3
Abidjan 2
Andover 2
Barcelona 2
Brno 2
Helsinki 2
Hillsboro 2
Hounslow 2
Kilburn 2
Laurel 2
Moscow 2
Oxford 2
Phoenix 2
Pianoro 2
Piombino 2
Prato 2
Verona 2
Ancona 1
Bath 1
Bergamo 1
Bhavnagar 1
Bologna 1
Bremen 1
Castelfiorentino 1
Catanzaro 1
Cecina 1
Cedar Knolls 1
Clamart 1
Dallas 1
Fiesole 1
Jinan 1
Kunming 1
Langfang 1
Legnano 1
Lemelerveld 1
Lonate Ceppino 1
London 1
Lyndhurst 1
Milan 1
Monte San Savino 1
Mountain View 1
Norwalk 1
Nürnberg 1
Pune 1
Ravenna 1
Redwood City 1
Rome 1
Siena 1
Solignano 1
Southwark 1
Turin 1
Washington 1
Xi'an 1
Xiamen 1
Totale 1.529
Nome #
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 153
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology. 141
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 124
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 124
CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients 113
The CADASIL scale: a screening tool to select patients for NOTCH3 gene analysis 110
Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients 108
Association of the Variant Cys139Arg at GRN Gene to the Clinical Spectrum of Frontotemporal Lobar Degeneration 101
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. 100
European Stroke Organisation Conference: Abstracts 100
Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. 95
The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases. 95
Familial cerebral cavernous malformation: report of a further Italian family 92
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 92
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 92
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia 89
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 89
Inherited leukoencephalopathies with clinical onset in middle and old age 89
High lipoprotein(a) serum levels in three CADASIL families. 86
Cerebral hemorrhages in CADASIL: report of four cases and a brief review. 82
Mutation screening of HTRA1 gene in NOTCH3-negative patients with cerebral small vessel disease 53
Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis” 51
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 42
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 42
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry 26
Totale 2.289
Categoria #
all - tutte 7.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020335 0 0 0 34 45 49 54 45 46 29 26 7
2020/2021150 16 11 15 10 7 18 3 10 20 12 14 14
2021/2022135 3 11 13 3 3 9 6 9 7 5 17 49
2022/2023498 48 117 20 42 25 86 58 19 53 0 23 7
2023/2024203 5 18 25 8 18 33 5 54 3 10 17 7
2024/2025438 57 133 79 169 0 0 0 0 0 0 0 0
Totale 2.289